These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 27050301

  • 1. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.
    Huang Y, Zhang Q, Wang JR, Lin KL, Mei X.
    Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Amino acids as co-amorphous excipients for simvastatin and glibenclamide: physical properties and stability.
    Laitinen R, Löbmann K, Grohganz H, Strachan C, Rades T.
    Mol Pharm; 2014 Jul 07; 11(7):2381-9. PubMed ID: 24852326
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Application of Central Composite Design in Optimization of Valsartan Nanosuspension to Enhance its Solubility and Stability.
    Vuppalapati L, Cherukuri S, Neeli V, Yeragamreddy PR, Kesavan BR.
    Curr Drug Deliv; 2016 Jul 07; 13(1):143-57. PubMed ID: 26205900
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Performance comparison between crystalline and co-amorphous salts of indomethacin-lysine.
    Kasten G, Nouri K, Grohganz H, Rades T, Löbmann K.
    Int J Pharm; 2017 Nov 25; 533(1):138-144. PubMed ID: 28947246
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Spray drying of poorly soluble drugs from aqueous arginine solution.
    Ojarinta R, Lerminiaux L, Laitinen R.
    Int J Pharm; 2017 Oct 30; 532(1):289-298. PubMed ID: 28890173
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ, Ranjan OP, Hussen SS, Krishna BS, Musmade PB, Gautham Shenoy G, Bhat K.
    Eur J Pharm Sci; 2014 Oct 01; 62():57-64. PubMed ID: 24878386
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aspartame as a co-former in co-amorphous systems.
    Wu W, Löbmann K, Schnitzkewitz J, Knuhtsen A, Pedersen DS, Grohganz H, Rades T.
    Int J Pharm; 2018 Oct 05; 549(1-2):380-387. PubMed ID: 30075253
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Formulation and Pharmacokinetic Evaluation of Polymeric Dispersions Containing Valsartan.
    Chella N, Daravath B, Kumar D, Tadikonda RR.
    Eur J Drug Metab Pharmacokinet; 2016 Oct 05; 41(5):517-26. PubMed ID: 26156887
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo comparison between crystalline and co-amorphous salts of naproxen-arginine.
    Kasten G, Lobo L, Dengale S, Grohganz H, Rades T, Löbmann K.
    Eur J Pharm Biopharm; 2018 Nov 05; 132():192-199. PubMed ID: 30266670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.